Indinavir clinical trials
How each study uses Indinavir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 13 Mar 1996 · CRIXIVAN · NDA 020685 (FDA, Drugs@FDA)
- European Union
- 4 Oct 1996 · Crixivan · EMEA/H/C/000128 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 1996 | 1 |
| 1999 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 28 · Other 24
Merck Sharp & Dohme LLC (17) · National Institute of Allergy and Infectious Diseases (NIAID) (16) · Pharmacia and Upjohn (3) · Glaxo Wellcome (3) · National Cancer Institute (NCI) (2) · Dupont Merck (2) · The HIV Netherlands Australia Thailand Research Collaboration (1) · Germans Trias i Pujol Hospital (1)
Often tested with
Tested in the same studies.
Ritonavir (14) · Lamivudine (13) · Zidovudine (12) · Stavudine (8) · Efavirenz (6) · Nelfinavir (6) · Delavirdine (4) · Saquinavir (3)
Related medicines
As reviewed, each with the page that says it.
- One of Protease Inhibitors source
Studies
Open first, then newest update. How each study uses Indinavir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 52
- The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One YearCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000848Written as Indinavir sulfate
- A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More MonthsCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00000841Written as Indinavir sulfate
- A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected PatientsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00001084Written as Indinavir sulfate
- Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV DrugsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00001083Written as Indinavir sulfate
- A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected PatientsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00001086Written as Indinavir sulfate
- Ritonavir and Indinavir in Children Failing Other Anti-HIV TreatmentCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00012519Written as indinavir sulfate
- Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or SaquinavirCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00001133Written as Indinavir sulfate
- A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their InfantsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000944Written as Indinavir sulfate
- Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative AdultsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000877Written as Indinavir sulfate
- Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected ChildrenCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000901Written as Indinavir sulfate
- Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320CompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000885Written as Indinavir sulfate
- The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected PatientsCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00000861Written as Indinavir sulfate
- The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving RifampicinCompletedPhase 1/2The HIV Netherlands Australia Thailand Research CollaborationNCT00411996Written as indinavir/ritonavir
- Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIVCompletedPhase 1Germans Trias i Pujol HospitalNCT00307502Written as Indinavir/ritonavir
- Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy VolunteersCompletedPhase 4National Institutes of Health Clinical Center (CC)NCT00050180Written as Indinavir
- A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)WithdrawnNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00000804Written as Indinavir sulfate
- A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and AmprenavirCompletedPhase 4Emory UniversityNCT00148785Written as Indinavir/Ritonavir/Fosamprenavir
- A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV InfectionCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00006154Written as Indinavir sulfate
- External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesStatus unknownPhase 2Oncology Institute of Southern SwitzerlandNCT00637637Written as indinavir sulfate
- Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced SubjectsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000882Written as Indinavir sulfate
Codes
What other systems call Indinavir · ClinicalTrials.gg INT008708
- MeSH (NLM) D019469IndinavirConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 5W6YA9PKKHINDINAVIRConfirmed FDA, NLM, Wikidata
- RxNorm 114289One source FDA
- Wikidata Q81976224Indinavir hydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66877IndinavirOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019469 | Indinavir | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 5W6YA9PKKH | INDINAVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 114289 | — | One source FDA |
| Wikidata | Q81976224 | Indinavir hydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66877 | Indinavir | One source FDA |
Also registered as indinavir sulfate (UNII 771H53976Q · RxNorm 203153).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.